Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
April 15, 2008
Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I
Jennifer S Hackbarth, Marina Galvez-Peralta, Nga T Dai, et al.
The Journal of Biological Chemistry
|
February 28, 2004
Rad9 protects cells from topoisomerase poison-induced cell death
David Loegering, Sonnet J H Arlander, Jennifer Hackbarth, et al.
Nature Communications
|
October 13, 2019
ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer
Arun Kanakkanthara, Catherine J Huntoon, Xiaonan Hou, et al.
Nature Metabolism
|
July 6, 2021
Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect
Elizabeth K Wiese, Sadae Hitosugi, Sharon T Loa, et al.
Molecular Pharmacology
|
May 30, 2008
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines
Marina Gálvez-Peralta, Nga T Dai, David A Loegering, et al.
BMC Bioinformatics
|
August 5, 2022
DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer
Shrabanti Chowdhury, Ru Wang, Qing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2012
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro
Erin L Schenk, Brian D Koh, Karen S Flatten, et al.
Gynecologic Oncology
|
November 4, 2011
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma
Andrea E Wahner Hendrickson, Ann L Oberg, Gretchen Glaser, et al.
Scientific Reports
|
March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Nicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
Cell Cycle (Georgetown, Tex.)
|
January 25, 2007
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo
David J Matthews, F Michael Yakes, Jason Chen, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
April 15, 2008
Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I
Jennifer S Hackbarth, Marina Galvez-Peralta, Nga T Dai, et al.
The Journal of Biological Chemistry
|
February 28, 2004
Rad9 protects cells from topoisomerase poison-induced cell death
David Loegering, Sonnet J H Arlander, Jennifer Hackbarth, et al.
Nature Communications
|
October 13, 2019
ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer
Arun Kanakkanthara, Catherine J Huntoon, Xiaonan Hou, et al.
Nature Metabolism
|
July 6, 2021
Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect
Elizabeth K Wiese, Sadae Hitosugi, Sharon T Loa, et al.
Molecular Pharmacology
|
May 30, 2008
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines
Marina Gálvez-Peralta, Nga T Dai, David A Loegering, et al.
BMC Bioinformatics
|
August 5, 2022
DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer
Shrabanti Chowdhury, Ru Wang, Qing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2012
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro
Erin L Schenk, Brian D Koh, Karen S Flatten, et al.
Gynecologic Oncology
|
November 4, 2011
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma
Andrea E Wahner Hendrickson, Ann L Oberg, Gretchen Glaser, et al.
Scientific Reports
|
March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Nicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
Cell Cycle (Georgetown, Tex.)
|
January 25, 2007
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo
David J Matthews, F Michael Yakes, Jason Chen, et al.
Page
of 6